Back
Speaker illustration

Doctor Nicholas Jones

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

Presentations Articles

Low dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: the BARACK-D randomised trial

Event: ESC Congress 2024

Topic: e-Cardiology/Digital Health

Session: Nature Medicine: 2024 highlights in personalised cardiovascular medicine

Access
Like
Thumbnail

Body mass index and survival in people with heart failure

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure - Epidemiology, prognosis, outcome 2

Access
Like
Thumbnail

Survival among people with heart failure and atrial fibrillation; a population cohort study

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure and atrial fibrillation

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources